help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GOLDSTEIN, A. B.
Right arrow Articles by TEPPER, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GOLDSTEIN, A. B.
Right arrow Articles by TEPPER, R. S.

Am. J. Respir. Crit. Care Med., Volume 164, Number 3, August 2001, 447-454

Bronchodilator Responsiveness in Normal Infants and Young Children

AMY B. GOLDSTEIN, ROBERT G. CASTILE, STEPHANIE D. DAVIS, DAVID A. FILBRUN, ROBERT L. FLUCKE, KAREN S. McCOY, and ROBERT S. TEPPER

Section of Pediatric Pulmonary Medicine, Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio; and Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, Indiana

Several studies have demonstrated that normal infants exhibit bronchoconstriction after inhalation of nonspecific agonists and that the induced airway narrowing can be reversed by the inhalation of a beta -agonist. However, there are very limited data on baseline airway tone and the airway response to a beta -agonist in this subject population. The purpose of our study was to evaluate in normal infants baseline airway responsiveness to the inhaled beta -agonist, albuterol, using changes in maximal expiratory flows. Forty-one healthy infant volunteers with no history of respiratory disease or recurrent wheezing (ages 5.4 to 141.4 wk) were studied. Maximal expiratory flow- volume curves were obtained at baseline and 10 min after inhalation of albuterol (n = 28) or placebo (n = 13) using a metered-dose inhaler with a spacer. The mean percent change was significantly greater (p < 0.05) in the albuterol versus placebo group for FEV0.5 (2.2% versus -1.5%), FEF75% (10.6% versus -3.1%), and FEF85% (12.9% versus 0.5%). Six of 28 albuterol-treated infants demonstrated increases in FEF75% greater than two standard deviations from the mean change in FEF75% seen in the placebo group. These infants were younger and more frequently exposed to maternal smoking during pregnancy. We conclude that normal healthy infants have overall levels of baseline airway tone that are similar to that reported in adults and older children; however, among the infants we evaluated the response to an inhaled bronchodilator was greatest in the youngest infants and in those exposed to tobacco smoking.

Keywords: airway responsiveness; asthma; tobacco smoke; infant pulmonary function; bronchodilator




This article has been cited by other articles:


Home page
 ThoraxHome page
L M Borrego, J Stocks, P Leiria-Pinto, I Peralta, A M Romeira, N Neuparth, J E Rosado-Pinto, and A-F Hoo
Lung function and clinical risk factors for asthma in infants and young children with recurrent wheeze
Thorax, March 1, 2009; 64(3): 203 - 209.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
ATS/ERS Statement: Raised Volume Forced Expirations in Infants: Guidelines for Current Practice
Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1463 - 1471.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
D. A. Straub, A. Moeller, S. Minocchieri, J. Hamacher, F. H. Sennhauser, G. L. Hall, and J. H. Wildhaber
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma
Eur. Respir. J., February 1, 2005; 25(2): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A.-F. Hoo, J. Stocks, S. Lum, A. M. Wade, R. A. Castle, K. L. Costeloe, and C. Dezateux
Development of Lung Function in Early Life: Influence of Birth Weight in Infants of Nonsmokers
Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 527 - 533.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
H. B. Panitch
The Role of Pulmonary Function Testing in Infants
NeoReviews, May 1, 2004; 5(5): e183 - e185.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
M. R. Perez and D. J. Weiner
Measurement of Forced Expiratory Flows and Lung Volumes
NeoReviews, May 1, 2004; 5(5): e202 - e207.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. K. Lambert, R. G. Castile, and R. S. Tepper
Model of forced expiratory flows and airway geometry in infants
J Appl Physiol, February 1, 2004; 96(2): 688 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. Beydon, I. Pin, R. Matran, M. Chaussain, M. Boule, B. Alain, M. Bellet, F. Amsallem, C. Alberti, A. Denjean, et al.
Pulmonary Function Tests in Preschool Children with Asthma
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 640 - 644.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. H. Jones, J. Howard, S. Davis, J. Kisling, and R. S. Tepper
Sensitivity of Spirometric Measurements to Detect Airway Obstruction in Infants
Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1283 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
F. E. Leickly
Bronchodilator Responsiveness in Normal Infants and Young Children
Pediatrics, August 1, 2002; 110(2): 448 - 449.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  Tobacco